Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059186) titled 'Reexamination of the correlation between caffeine concentrations in blood and saliva' on Oct. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Department of Pharmacology, Graduate School of Medicine, Ehime University
Condition:
Condition - Healthy adult men and women
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To verify the correlation between caffeine concentrations in blood and saliva when caffeine is ingested
Basic objectives2 - Pharmacokinetics
Intervention:
Interventions/Control_1 - A beverage containing 150 mg of caffeine in 200 mL of water
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy males and females aged 20 to 60 years
Key exclusion criteria - None
Target Size - 10
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 21 Day
Date of IRB - 2025 Year 09 Month 22 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067675
Disclaimer: Curated by HT Syndication.
